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INTRODUCTION 
 
Retrocochlear space occupying lesions can be a life threatening 
condition presenting in different stages ranging from subtle otologic 
symptoms to life endangering tonsillar herniation and death. 
 
The various retrocochlear space occupying lesions are Acoustic 
Schwannomas, Meningiomas, Epidermoid Cysts, Arachnoid Cysts, 
Schwannomas of the 5th, 7th, 9th, 10th or 11th cranial nerves, Hemangiomas, 
Lipomas or Dermoid Cysts. Of all these, Acoustic Schwannomas in the 
cerebellopontine angle constitute 60- 90%. Next in frequency are 
Meningiomas, Epidermoid Cysts and Arachnoid Cysts.  
 
Since these lesions are slow growing and initially may present with 
subtle clinical symptoms, the Otorhinologists must maintain a high index of 
suspicion and use appropriate audiologic , vestibular and radiographic 
studies to diagnose these lesions at the earliest stage. Since there is no single 
audiologic test to detect a retrocochlear lesion , the patient has to undergo a 
battery of tests which are Puretone Audiometry, Speech Audiometry, Special 
Tests and Brainstem Evoked Response Audiometry. 
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 Early diagnosis if made with these tests, is of advantage since it can 
limit surgical morbidity and facilitate Facial Nerve and hearing 
preservation.and can be applied in Community Otorhinology. This study is 
on the efficacy of various audiological tests in the detection of retrocochlear 
space occupying lesions.      
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AIM OF STUDY 
 
1) To study the efficacy of various audiological tests in 
detecting retrocochlear space occupying lesions . 
 
2) To study the efficacy of Brainstem evoked response 
audiometry in screening for retrocochlear space 
occupying lesions . 
 
3) To evaluate the gold standard test in the diagnosis of 
retrocochlear space occupying lesions. 
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REVIEW OF LITERATURE 
 
Historical Perspective: 
 
Vestibular Schwannomas were described in the latter part of the 
seventeeth century. The clinical symptom in patients with Vestibular 
Schwannomas were correlated with intracranial autopsy findings. By mid 
1800s, neurologists understood that a tumour in the affected 
cerebellopontine angle patients who manifest with unilateral deafness, facial 
numbness and progressive blindness. The earliest attempts  at removal of the 
cerebellopontine angle tumour was first performed by McBurney and the 
first successful results  were achieved by Balance and Annandale. Cushing, 
followed by Dandy and Olivecrona initiated the next era in Vestibular 
Schwannoma surgery. The modern era of Vestibular Schwannoma surgery 
has been dominated by the efforts of House, Yasrgil, and Fisch, Glasscock, 
Tos and Thomsen, Palva, Sterkers, King and Morison, Samii and Wigand. 
 
The translabyrinthine approach to the cerebellopontine angle was first 
suggested by Panse in 1904, first performed by Quix in 1911, and later used 
by Schniegelow and others to remove Vestibular Schwannomas. Benefiting 
from improved instrumentation and magnification , House and Hitselberger, 
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in the 1960s, revived the translabyrinthine approach to the lesions of the 
cerebellopontine angle. 
 
Anatomy Of The Cerebellopontine Angle 
 
 The cerebellopontine angle is a triangular area bounded laterally by 
the medial portion of the posterior surface of the temporal bone, medially by  
edges of the pons and posteriorly by the anterior surface of cerebellar 
hemisphere and the flocculus and is part of the lateral medullary cistern. 
Superiorly it is limited by the Trigeminal Nerve as it crosses the petrous 
apex and by the edge of the tentorium. Its inferior limit is formed by the 
lower cranial nerves as they enter the Jugular Foramen and by the 
Hypoglossal  Nerve. It  contains an important artery, the Anterior Inferior 
Cerebellar Artery and two cranial nerves namely the Facial and the 
Vestibulocochlear Nerve as they pass from their parts of origin at the 
pontomedullary junction towards the Internal Acoustic Meatus. 
 
The  Internal Acoustic Meatus is a passage though the petrous bone 
leading to the medial wall of the vestibule. It has a porous or inlet medially 
and fundus laterally which is separated from the vestibule by a thin plate of 
bone. The lateral wall of the meatus is divide into superior and inferior 
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halves by the falciform crest. The upper compartment is further divided into 
an anterior area for the Facial Nerve and a posterior area for the Superior 
Vestibular Nerve by a sharp vertical ridge of bone known as Bill’s Bar. The 
lower halve also comprises of two areas, anteriorly the Tractus Spiralis 
Foraminosus through which the spiraling fibres of the cochlear nerve pass 
and the posteriorly rather smaller area for the vestibular nerve. 
 
Differential diagnosis of Tumours of the Internal Auditory Canal and 
the Cerebellopontine angle: 
 
 Although the most common tumour associated with the 
cerebellopontine angle syndrome is acoustic schwannoma, many other 
neoplastic and non-neoplastic mass lesions occur in the region. 
 
CLASSIFICATION AND FREQUENCY OF CEREBELLOPONTINE 
ANGLE LESIONS: 
 
Primary Tumours of the 
CPA 
Revilla 
(1947)% 
Brackmann 
(1980)% 
Valavanis 
(1987)% 
Acoustic Schwannoma 75.1 91.3 60.5 
Meningioma 6.3 3.1 6.8 
Epidermoid  6.3 2.4 3.7 
Arachnoid Cyst - 0.5 2.0 
Schwannoma of the 
  5,7,9,10,11CN 
4.9 1.4 4.0 
Primary Melanoma 0.5 - 0.2 
Hemangioma - 0.3 0.7 
Lipoma,Dermoid, - 0.4 - 
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Thus the few most common tumours are the same in all the three 
series ; acoustic schwannoma, meningioma, arachnoid cyst and non-acoustic 
posterior fossa schwannoma. Together they account for 75% to 98% of all 
cerebellopontine angle lesions. 
 
The three most common lesions in adults- acoustic schwannoma, 
meningioma, and  epidermoid cyst – are the same in older teenagers. In 
younger children acoustic schwannomas are extremely rare and gliomas 
which are capable of enlarging the internal acoustic canal are the most 
common cause of cerebellopontine angle tumours2.  
ACOUSTIC SCHWANNOMAS  
 
      Acoustic schwannomas account for about 8% to 10% of all the 
intracranial tumours and about 60 – 90% of all the cerebellopontine angle 
tumours. They are schwannomas that arise from the vestibular division of 
the eighth cranial nerve3,4. Because the term acoustic neuroma is a 
misnomer, a subject recommended that this widely used term  be replaced by 
the more accurate Vestibular Schwannoma. Although formerly some have 
maintained that superior vestibular schwannomas predominate, current 
opinion favours an equal origin in both superior and inferior divisions of the 
nerve5.  
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    The eighth nerve is unusual among cranial nerves in that it possesses a 
long   segment of central myelin. It has been proposed that acoustic 
neuromas may arise in  the region of the transition zone between the central 
and peripheral myelin, also known as the Obersteiner – Redlich Zone6. The 
recent literature indicates that most vestibular schwannomas originate lateral 
to the glial- schwannian junction of the nerve and not from the transition 
zone7. 
In larger tumours it is seldom possible to ascertain the precise site of 
origin along the nerve. Observations from smaller tumours  indicate that 
most acoustic neuromas arise in the internal auditory canal.    
MOLECULAR GENETICS: 
 
Great studies have been made in the recent years concerning the 
genetic basis of  acoustic neuroma formation. Through a variety of 
molecular genetic techniques , the gene responsible for acoustis neuroma  
associated with NF-2 has been localized to the long arm of the chromosome 
22. The disease gene was identified in 1993, and codes for a 587 aminoacid 
protein. The NF-2 gene has been shown to be inactivated  both by familial as 
well as sporadic cases. Two mutations are required to induce an acoustic 
neuroma- one that damages each chromosomal copy. 
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This” double hit” theory fits well with theories on the genetic origin of 
sporadic acoustic neuromas as well as those associated with NF-2. In 
sporadic acoustic neuromas two silencing mechanisms must occur in one 
cell to incite tumour growth. For this to occur it must be assumed that the 
gene has a high spontaneous mutation rate. Patients with NF-2 gene carry a 
defective copy of the gene so, when a spontaneous event inactivates the  sole 
remaining functional copy of the acoustic neuroma suppressor gene, a 
tumour results. 
 
Endocrine Relationships 
 
Clinical series have consistently observed a slightly higher incidence 
of acoustic neuroma in women than men, particularly postmenopausal 
women8. Also, the onset of NF-2 may be earlier in women than men. It has 
also been proposed that the acoustic neuroma growth may accelerate during 
pregnancy. High affinity estrogen and  progesterone receptors have been 
identified in the tumours.  
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Gross Pathology: 
 
 
Majority of acoustic neuromas are benign, relatively slowly growing 
neoplasms. On gross inspection they are usually yellowish- white or gray 
encapsulated and frequently possess cystic components. Internally appear 
heterogenous and contain interspersed regions of soft and firm consistency. 
Their surface is typically smooth and regular. The most pronounced 
vascularity appears on the tumour surface, taking its origin from the 
numerous small vessels of the Internal Auditory canal, cerebellopontine 
angle, and brainstem surface. 
HISTOPATHOLOGY 
 
Histopathologic examination reveals two types of morphologic 
patterns; Antoni A and Antoni B. Antoni A type describes a densely packed 
cells with small ,spindle-shaped densely staining nuclei. Antoni B type 
refers to a looser cellular aggregation of vacuolated pleomorphic cells. The 
Antoni B morphology sems to occur predominantly in larger tumours. A 
whorled appearance of Antoni type A cells is a verrocay body. In Antoni B 
configurations the presence of large atypical hyperchromatic nuclei has been 
termed as ancient schwannoma by pathologists. A positive S-100 
immunoperoxidase stain is confirmatory of schwann cell origin. During their 
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growth acoustic neuromas are “pushers” that progressively displace adjacent 
structures, often without  macroscopic signs of invasion. Degeneration of a 
benign acoustic neuroma into a malignant schwannoma has been reported 
but is exceedingly rare9.   
Growth rate 
 
The growth rate of acoustic neuromas has been studied both in vitro 
and in vivo. The fraction of dividing cells in an  acoustic neuromas has been 
assessed by immunohistochemical means with the fraction of proliferating 
cells ranging between 0.36% and 3.15%10. When the available data are 
analysed acoustic neuromas increase in diameter on an average of 0.1cm to 
0.2cm per year. 
 
SYMPTOMATIC PROGRESSION OF ACOUSTIC 
NEUROMA WITH TUMOUR GROWTH: 
 
 
Intracanalicular Hearing loss , Tinnitus , Vertigo 
Cisternal Hearing loss , Vertigo diminishes, 
Disequilibrium 
Brainstem compressive Midfacial and Corneal Hypoaesthesia 
Occipital Headache, Ataxia Begins 
Hydrocephalic Worsening Trigeminal symptoms, Gait 
deteriorates, Blurred vision, Lower cranial 
Nerve Dysfunction , Death due to Tonsillar 
Herniation 
 
11 
CLINICAL FEATURES: 
Cushing’s classical description of the clinical features (described in 
1917) and  quoted by Shephard and Wadia : 
 
STAGE  1 Stage of hearing disorder and vestibular manifestations 
STAGE  2 Occipitofrontal Pains 
STAGE  3 Incordination and instability of cerebellar origin 
STAGE  4 Cranial Nerve Involvement 
STAGE  5 Increased Intracranial Tension 
STAGE  6 Dysarthria and Dysphagia 
STAGE  7 Cerebellar crisis with respiratory difficulties 
 
 
Jackler R.K has divided the growth into four anatomical stages viz. 
 
Intracranial stage Confined to the Internal Auditory Canal 
Cisternal stage Projects into the Cerebellopontine Angle 
Cistern, 7th and 8th nerve displaced 
Brainstem Compressive 
Stage 
Lateral surface of Pons gets compressed 
 
Hydrocephalic stage Fourth ventricle gets compressed 10th ,11th, 
12th cranial nerve involvement 
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SIGNS AND SYMPTOMS 
 
Hearing Loss 
 
Occuring in over 95% of patients , hearing loss is the most frequent  
symptom of acoustic neuromas. A number of mechanisms have been 
theorized. Direct eighth nerve compression , stretching of the nerve vascular 
compression , or occlusion of the blood supply of the eighth nerve  or the 
cochlea , damage to the cochlear efferents , biochemical changes within the 
inner ear, and hemorrhage within the nerve or into the tumour all have a 
place in the etiology of hearing loss. 
 
The rate and amount of hearing loss will vary depending on the rate of 
growth of tumours , the location within the internal auditory canal and the 
amount of early expansion into the cerebellopontine angle. 
 
Schuknecht and Woellner11 demonstrated if the Organ of Corti is 
intact 75% of the auditory fibres need to be destroyed before the pure tone 
hearing is affected. This explains the typical , slowly progressive hearing 
loss of cerebellopontine angle tumours. Sando12 demonstrated anatomically 
that the high frequency auditory nerve fibres from the basal turn of the 
cochlea are located inferiorly and laterally all the way from the spiral 
ganglion to the cochlear nuclei in the brainstem, whereas the middle and 13 
apical fibres twist about the axis from the spiral ganglion to the cochlear 
nuclei. Low frequency apical fibres are located more centrally within the 
nerve. These differences in the position within the nerve may be the reason 
for earlier involvement of high frequency basal fibres and a variable 
involvement of the middle and low frequency fibres from the middle and 
apical turns of the cochlea. 
 
Badie and colleagues13   proposed a theory of increased pressure in the 
internal  auditory  canal as a cause for tumour related hearing loss. 
Atypical forms of hearing loss are relatively frequent. A sudden decrease in 
hearing occurs in some 26% of  acoustic neuromas14. The loss may be partial 
or total and spontaneous recovery is possible. The diagnostic dilemma stems 
from the fact that only 1 -2 % of patients who have sudden hearing loss will 
ultimately prove to have an acoustic neuroma. 
 
A small fraction of  patients with acoustic neuromas have either 
normal hearing or symmetrical hearing loss. Before the era of high 
resolution imaging , most series showed 1-3% of patients with acoustic 
neuromas had normal hearing. In a recent series from the Magnetic 
Resonance Imaging era , 15% of patients with acoustic neuromas had 
subjectively normal hearing of whom 4% were audiometrically normal15. 
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Tinnitus 
In 70%  of the patients , tinnitus accompanies the deafness in acoustic 
neuromas but may also  present without any concomitant deafness in a small 
number of cases. 
VERTIGO, DYSEQUILIBRIUM AND DYSMETRIA  
 
True vertigo which is a sensation of spinning is not commonly 
associated with acoustic neuromas. In a recent series only 19% of 
individuals reported this symptom, most of whom had small tumours. 
Dysequilibrium is more prevalent than vertigo, occurring in nearly 50% of 
patients and occurs in larger tumours14. Larger tumours (more than 3 cm ) 
have a higher than 70% incidence of this symptom. 
  
Overt cerebellar dysfunction is limited to large tumours , which indent 
the lateral cerebellar lobe and peduncles and impair the output of the 
ipsilateral cerebellar hemisphere. Truncal ataxia was found to be more 
common than limb ataxia. 
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FACIAL ANESTHESIA AND PAIN 
 
Facial sensory disturbance occurs in approximately 50% of tumours 
larger than 2cm and is rarely present with smaller lesions14. Hypoesthesia of 
the midfacial region is the most common symptom. Gradually the upper and 
the lower divisions of the trigeminal nerve become involved. Facial Pains 
may also result from acoustic neuromas. 
Dysfunction of the motor division of the trigeminal nerve is a symptom 
limited to a few advanced acoustic neuromas. 
FACIAL WEAKNESS AND SPASM 
 
The disturbances of facial  mimetic function are uncommon during the 
natural history of an  acoustic neuromas growth though the location of facial 
nerve is in the epicenter of the tumour growth. The facial nerve can sustain 
substantial compression, stretch and torsion from an acoustic neuroma and 
maintain its  functional integrity. Facial twitching occurs in approximately 
10% of patients14, and is independent of tumour size. The most common 
manifestation is a minor quivering of orbicularis oculi muscle. 
Abnormalities in evoked electromyography and the blink reflex may be 
demonstrated in a minority of patients with apparently normal facial 
function. 
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The sensory component may be affected causing diminished sensation 
over the posterior aspect of ear canal and conchal bowl called Hitzelberger’s 
sign which is of little practical significance. 
 
HEADACHE 
 
The incidence depends on the size. Very few patients with small 
tumours have headaches.The incidence is approximately 20% in medium 
sized and more than 40% in large tumours14. Most commonly it is either 
focused in the suboccipital region or generalized. 
OPHTHALMOLOGIC MANIFESTATIONS  
Nystagmus 
 
A degree of  spontaneous nystagmus in the horizontal plane is 
frequent even with small tumours. With  large tumours , pronounced vertical 
plane nystagmus may be seen as a consequence of brainstem compression. 
Brun’s nystagmus is a peculiar  type of gaze nystagmus found in 
cerebellopontine  angle tumours compressing upon the pons , in which there 
is a large , coarse nystagmus on the side of the tumour and a fine, high 
frequency nystagmus on the normal side. 
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Decreased  corneal sensation is due to involvement of ophthalmic 
division of trigeminal nerve and indicates a large tumour. 
 
Papilledema from hydrocephalus is another important ophthalmologic 
manifestation. Hydrocephalus was found in 4% of patients14. Diplopia due to 
paralysis of fourth or sixth nerves by a large acoustic neuromas is extremely 
rare. 
LOWER CRANIAL NERVES 
Dysfunction of the lower cranial nerves ie, 9, 10, 11, 12 th is rare; making up 
3.5%. 
LATE SYMPTOMS 
 
Long tract signs, depressed conciousness , and stupor, leading onto 
coma and respiratory arrest. 
SUDDEN NEUROLOGIC DETERIORATION 
 
Intratumoral haemorrage is a rare occurance but is a cause of sudden 
neurologic deterioration due to onset of an acute cerebellopontine angle 
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AUDIOMETRIC EVALUATION 
PURETONE AUDIOMETRY 
In unilateral or bilateral deafness puretone audiometry is the key 
investigation. High frequencies are affected first. The hearing loss may 
range from very mild deafness to near total deafness and sometimes normal 
hearing also15.  
Normal hearing is defined as : 
1) Puretone average less than 20db 
2) Speech discrimination score more than 90% 
3) Interaural difference less than or equal to 10dB at every hertz   
frequency 
 
Abnormal audiometry is defined as an interaural difference of more 
than or equal to 15db at a single frequency or more than or equal to 10db at 
two or more frequencies , and an interaural speech reception threshold 
difference of more or equal to 20db or a discrimination score or more or 
equal to 20%16. 
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The pathophysiological basis for the typical hearing loss in patients with  
retrocochlear disease is a reduction in the number of  active fibres in the 
acoustic nerve and it was to be expected that abnormal findings would be 
present especially in those  tests that exert the greatest demands on the total 
transmission capacity of the nerve17. 
SPEECH AUDIOMETRY 
In this test the patient’s ability to  hear and understand  speech is 
measured. Two parameters are studied 1) Speech Reception Threshold 2) 
Descrimination Score 
SPEECH RECEPTION THRESHOLD (SRT) 
It is the minimum intensity at which 50% of the words are repeated 
correctly by the patient. A set of spondee (two syllable words with equal 
stress on each syllable)  words is delivered to each ear through the 
headphone of the audiometer. The word lists are delivered in the form of 
recorded tapes or monitored voice  and their intensity varied in 5dB steps till 
half of them are correctly heard. Normally SRT is within 10 dB of the 
average of puretone threshold  of three speech frequencies (500dB, 1000dB, 
and 2000dB) . 
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SPEECH DISCRIMINATION SCORE (SDS) 
 
Also called speech recognition score or word recognition score. It is a 
measure of patient’s ability to understand speech. Here a list of phonetically 
balanced (single syllable words ) is delivered to the patient’s ear separately 
at 30-40 dB above his SRT and the percentage of words correctly heard by 
the patient is recorded. In normal persons and in patients with conductive 
hearing loss a high score of 90% -100% can be obtained. A score of 60-90% 
is found in sensorineural hearing loss, and less than 30% indicates a 
retrocochlear pathology. 
ROLL OVER PHENOMENON 
 
This is seen in retrocochlear hearing loss . With an increase in speech 
intensity above a particular level the phonetically balanced word score falls  
rather than maintain a plateau as in cochlear type of sensorineural hearing 
loss. Retrocochlear lesions usually show a roll-over ratio of more than 0.45 
on speech audiometry, and have an abnormal tone decay. These two tests 
remain widely used and when abnormal triggers the next step in the 
diagnosis algorithm. 
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SHORT INCREMENT SENSITIVITY INDEX 
 
Patients with cochlear lesions distinguish smaller changes in intensity 
of puretone better than normal persons and those with conductive or 
retrocochlear pathology. SISI test is thus used to differentiate a cochlear 
from a retrocochlear pathology.  
 
In this test , a continuous tone is presented 20dB above the threshold 
and sustained for about 2 minutes. Every 5 seconds, the tone is increased by 
1 dB and 20 such blips are presented. Patients indicates the blips heard. In 
conductive deafness , SISI score is seldom more than 15%; it is 70%- 100% 
in cochlear deafness and 0- 20% in nerve deafness. 
 
THRESHOLD TONE DECAY TEST: 
 
It is a measure of nerve fatigue and is used to detect retrocochlear 
lesions. Normally, a person can hear a tone for 60 seconds. In nerve fatigue , 
he stops hearing earlier. The threshold tone decay test is simple and is 
performed in the following manner. 
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A tone of 4000Hz is presented at 5dB above the patient’s threshold of 
hearing , continuously for a period of 60 seconds . If the patient stops 
hearing earlier, intensity is increased by another 5 dB. The procedure is 
continued till the patient can hear continuously for 60 seconds or no level 
exists above the threshold where tone is audible for full 60 seconds. The 
result is expressed as number of dB of decay. A decay more than 25dB is 
diagnostic of a retrocochlear lesion. 
 
RECRUITMENT 
 
It is a phenomenon of abnormal growth of loudness.The ear which 
does not hear low intensity sound  begins to hear greater intensity sounds as 
loud or even louder than the normal hearing  ear. Recruitment is typically 
seen in patients with cochlear lesions and thus helps to differentiate a 
cochlear from a retrocochlear sensorineural hearing  loss. 
 
ALTERNATE BINAURAL LOUDNESS BALANCE TEST: 
 
This is used to detect recruitment in unilateral cases. A tone  is played 
alternately to the normal and affected side and the intensity in the affected 
ear is adjusted to match the loudness in the normal ear.The test is started at 
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20dB above the threshold of deaf ear and then repeated at every 20dB rise 
until the loudness is matched or the limits of the audiometer reached. In 
conductive and neural hearing loss , the initial difference is maintained 
throughout while in lesions of the cochlea partial, complete, or over-
recruitment may be seen.  
CALORIC TEST: 
Because the majority of tumours arise from the divisions of the 
vestibular nerve, it is hardly surprising that the Bithermal Caloric Test of 
Fitzgerald and Hallpike (1942) frequently reveals a canal paresis. 20% of the 
patients with tumours of less than 2cm or less can have a normal caloric 
response.(Gibson and Morison 1976) Welling reported a significant canal 
paresis in only 66% of tumours. It does appear that in the quest for diagnosis 
of small tumours , the caloric test has been largely superseded by more 
sensitive techniques. One should remember that the caloric test produces a 
maximum stimulus in the horizontal semicircular canal which is innervated 
by the superior vestibular nerve. A small tumour arising in the  inferior 
vestibular nerve may not cause any reduction in the caloric response.Some 
surgeons regard this finding as a good prognostic indication for hearing 
preservation, but there is no universal agreement on this point. 
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OTOACOUSTIC EMISSIONS (OAE) 
 
They are low intensity sounds produced by outer hair cells of a normal 
cochlea and can be elicited by a very sensitive microphone placed in the 
external ear canal  and an analysis by a computer. OAEs are present when 
outer hair cells are healthy and are absent when they are damaged and thus 
help to test the function of the cochlea. They do not disappear in eighth 
nerve pathology as cochlear hair cells are normal. 
 
All patients having a unilateral sensorineural deafness should be 
subjected to these tests. 
BRAINSTEM EVOKED RESPONSE AUDIOMETRY (BRAINSTEM 
AUDITORY EVOKED RESPONSE ) -BERA 
 
 
The auditory brainstem response is a measure of the electrical events 
generated in response to an auditory stimulus  by components along the 
auditory pathway picked up by using surface electrodes. 
 
BAER was first described by Jewett in 1970. It was first described for 
the diagnosis of acoustic neuromas in 1977 by Selters and Brackmann18. As 
the impulses pass  through the different situations in the auditory pathway it 
undergoes some degree  of processing at each of the stations. Passage of the 
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impulse through each of these pathway generates  electrical activity that can 
be measured by placing a surface electrode on the vertex of the scalp. On 
graphic recording this electrical activity presents wave forms with discrete 
peaks the character of which is dependent upon the functional and structural 
integrity of the above mentioned auditory pathway. By analysis of the wave 
forms and its peaks as regards latency,  amplitude, wave morphology, etc, 
we can have a fairly accurate idea about any abnormality in this pathway. 
 
A number of responses called auditory evoked potentials can be 
recorded. The evoked transient responses can be recorded upto 500 
milliseconds  from the time of onset of the sound stimulus. Of this duration 
of 500 milliseconds  the auditory evoked potentials of the first 10 
milliseconds , called early phase of transit response , or Short Latency 
Response (SLR) is called the Brainstem Evoked Response Audiometry, 
since it records the auditory evoked potential when the auditory stimulus is 
traversing the brainstem region.  
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METHOD OF RECORDING BERA 
The auditory evoked potential is elicited by a click stimulus having an 
intensity of approximately 45 to 65 dB above the average pure tone hearing 
level of the subject and is recorded with  the active electrode placed over the 
vertex. One electrode called the reference electrode is placed on the mastoid 
of the ipsilateral ear and a ground electrode is placed either over the 
forehead just above the nasion or over the contralateral mastoid. Preferable 
to do a puretone audiogram prior to BERA because the sound stimulus has 
to be presented at a fixed suprathreshold  level (usually 60dB ) above the 
threshold and the interpretation of BERA is dependent on the audiometric 
contour. The sound stimulus is a broad band click of 100 microseconds 
duration.A broad click stimulates synchronously a large number of neurons 
and thereby  elicites a robust BERA tracing which is clear , sharp and well 
demarcated  with distinct and easily recognizable peaks in the graph. 
 
The stimulus rate or click frequency is between 10 -40 clicks per 
second. The recording  obtained is a graph plotted with amplitude in 
microvolts on the ordinate and time in milliseconds from the onset of 
stimulation on the abscissa. It consists  of five to seven peaks in a normal 
adult appearing within 8 – 10 milliseconds.   
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WAVE SITE OF NEURONAL GENERATOR 
1 Cochlear nerve (distal end) 
2 Cochlear nerve (proximal end) 
3 Cochlear nucleus 
4 Superior olivary complex 
5 Lateral lemniscus ? inferior colliculus 
6 Not definitely known 
7 Not definitely known 
 
INTERPRETATION OF BERA RESPONSE  
A normal BERA recording is shown in figure (i) 
 
It has five prominent peaks and two small peaks , which are named 
from 1 to 7 , each giving information about a specific segment of the 
auditory pathway from cochlea to brainstem; hence the need of identifying 
each wave accurately. 
 
Wave 5 is the most reliable and easily identifiable wave  in BERA 
tracing. The hallmark of wave 5 is that there is a sharp negative deflection 
immediately following a peak beyond 5 milliseconds mark. 
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NORMAL BERA WAVES 
 
 
 
 
 
 
 
Wave 4 is identified as the peak just preceding wave 5. A distinct and 
separately identifiable wave 4 is present in only 50-60% of subjects. In other 
cases the wave cannot be identified separately. 
 
       Wave 3 is identified as the upward peak between Wave 2 and Wave 4,  
just beyond the 3 millisecond on the graph. It is consistent as Wave 1 and 
Wave 5 and may be absent in only about 1-2% of cases. It is normally 
present around the 3.8 millisecond mark on the BERA graph. 
 
Wave 2 is the peak immediately preceding the easily recognizable 
Wave 3 and has a latency of approximately 2.8 milliseconds. 
 
Wave 1 is the sharp peak just  beyond the 1 millisecond mark on the 
BERA graph, usually present at 1.65 to 1.75 milliseconds. It is a consistent 
wave and is present in all normal subjects.  
 
The parameters used frequently are : 
1) Ipsilateral latency of potential Wave 5 as compared to normal. 
2) Difference of latency of potential Wave 5 of ipsilateral and 
contraleral sides. 
3) Ipsilateral latency difference of Wave 1 to 5 as compared to 
normal. 
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4) Difference of latency potentials of Waves 1 and 5 of ipsilateral and 
contralateral side. 
 
Comparing latency difference of potentials of ipsilateral and 
contralateral sides was the safest method to avoid a false positive 
diagnosis19. 
 
The absolute latency of Wave 5 is most important for clinical 
measurement because it is commonly present and easily identifiable and 
because the latency of Wave 5 is dependant upon the intensity of sound 
stimulus. 
 
The interaural latency of a particular wave should not be more than 
0.2 millisecond provided the same suprathreshold sound is presented to both 
ears . If the difference is more than 0.3 milliseconds existence of some lesion  
in the vestibular pathway should be suspected. The interwave latency 
measured shows any lesion between the cochlear nerve and the brainstem. It 
is approximately 4 milliseconds between Waves1 and 5.  
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AMPLITUDE STUDIES                                                                   
 
 Amplitude studies are not a very good criteria since the amplitude of 
the waves is not as constant as latency of the waves.They are variable and so 
the clinical information obtained are not much reliable. 
 
WAVE MORPHOLOGY 
 
Wave morphology ie, the shape or configuration of the graph that is 
obtained on evoked response audiometry also provides some clinical 
information. Any retrocochlear lesion may alter the morphology of the 
waves. 
 
BERA is the most sensitive and specific test in the audiology battery 
for detecting disorders that affect the brainstem. It is an inexpensive and 
noninvasive monitor of brainstem status in patients with confirmed or 
suspected brainstem disorders20. 
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SENSITIVITY OF BERA IN DETECTING ACOUSTIC NEUROMAS 
IN VARIOUS STUDIES21 
 
The overall sensitivity is 90% 
 
Roland(1987) 94% 
Harder(1988) 100% 
Josey(1988) 97% 
Moffet(1989) 93% 
Welling(1990) 92% 
Grabel(1991) 91% 
Wilson(1993) 85% 
Dornhoffer(1994) 93% 
Thomson(1994) 98% 
 
RELATIONSHIP BETWEEN TUMOUR SIZE 
AND BERA SENSITIVITY 
 
 
Study Tumour Size Sensitivity 
Hashimoto et al <1.5 cm 78% 
Wilson et al <1.5 cm 85% 
Gordon & Cohen et al <1 cm 69% 
Zappia et al <1 cm 89% 
Dornhoffer et al <1 cm 93% 
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THE STACKED ACOUSTIC BRAINSTEM RESPONSE 
 
The stacked Acoustic Brainstem Response was proposed by Don et al 
in 1997 and reflects the loss of synchronized neural fibre activity, no matter 
which fibres are compromised by the tumour. It is sensitive to neural fibre 
activity from all frequency regions of the cochlea. 
 
A click stimulus is used to activate the whole cochlea and the 
resulting response is separated into five frequency bands and are called 
derived band Acoustic Brain Responses and are used in constructing the 
stacked ABR. 
 
 In a series of 25 tumour cases, Don et al (1997) found that five small 
(<1cm) intracanalicular tumours were missed by standard ABR latency 
measures. However they demonstrated that all were detected by this new 
stacked ABR method. 
 
The main reason for the sensitivity of stacked ABR is that the 
temporal alignment and summation of derived waveforms to form a stacked 
ABR generate a stacked amplitude that reflects the total synchronous neural 
response to the stimulus. Thus the activity of all activity of neural elements 
contribute to the stacked amplitude. Elimination of any significant amount of 
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synchronous neural activity by the tumour will result in a significant 
reduction in the stacked ABR amplitude. Thus it is more sensitive than the 
standard latency and amplitude measures that require compromise of 
specific neural elements. 
 
A major limitation of stacked ABR is that  it must be obtained with 
click levels no greater than 60-65 dB nHL, because masking noise greater 
than this can be uncomfortable. 
IMAGING MODALITIES 
There have been four major eras in the evolution of imaging 
technology in the diagnosis of acoustic neuromas.Plain films of the internal 
acoustic meatus (1910s), Polytomography (1950s) Computed 
Tomography(1970s), Magnetic Resonance Imaging (1980s). Both plain 
films and polytomography rely on detection of osseous changes involving 
Internal Auditory Canal, and so were not sensitive . By comparing the 
normal Internal Auditory Canal to the abnormal side and using the criteria of 
a difference in canal height of more than 2mm, a shortening of the posterior 
wall of the canal of more than 3mm , a downward displacement of the crista 
falciformis , and the presence  of focal erosion, Valvassori found abnormal 
Internal Auditory Canals on polytomography in 78% of surgically verified 
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tumours22. Contrast enhanced Computed Tomography  and gas contrasted 
Compued Tomography improved the sensitivity but still small lesions were 
overlooked.  
 
The introduction of Magnetic Resonance Imaging in the early 1980s 
was a major improvement in acoustic neuromas diagnosis .Gadolinium 
enhanced  Magnetic Resonance Imaging further increased the sensitivity and 
is still the gold standard investigation23. 
 
Acoustic Schwannomas range in size from a few millimeters  to 6 cm-
8cm large tumours. A small percentage of tumours are entirely 
intracanalicular , majority are medium sized schwannomas (upto 2 cm) 
centered at the acoustic porus and a stem of tumour that extends into the 
Internal Auditory Canal, appearing as an ice-cream cone or mushroom. The 
very large tumours arise from the cisternal portion of the nerve and have 
little intracanalicular component. 
 
On non-contrast enhanced Computed Tomography 64% of acoustic 
neuromas are isodense. Nearly 90% of the untreated tumours enhance 
homogenously with contrast. 
35 
On Magnetic Resonance Imaging , medium sized tumours are most 
likely to be homogenous , and large tumours are likely to contain internal 
zones of inhomogenity. 
 
On T1-weighted images , schwannomas are usually isointense or 
mildly hypointense relative to the pons and hyperintense to CSF. On  T2-
weighted  images they are mildly hyperintense to the pons and iso- to 
hypointense to CSF. Thus CSF becomes a natural contrast for detecting the 
tumour. 
 
Acoustic schwannomas enhance intensity after intravenous 
administration of a gadonilium contrast agent on T1-weighted images. The 
sensitivity of contrast – enhanced, T1-weighted Magnetic Resonance 
Imaging can approach 100% in detecting schwannomas21,24. In a recent 
series , both contrast T1-weighted and high resolution T2-weighted images 
detected tumours ranging from 0.06 to 3.0 cm22,23. 
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MANAGEMENT  
 
Three treatment options are currently available: 
1) Observation with serial imaging 
2) Microsurgery 
3) Stereotactic radiation 
 
The choice of option is based on the preservation of life considering 
the natural course of these benign tumours and possible neurologic 
sequelae(eg, cranial nerve dysfunction, ataxia ), tumour removal, 
preservation of facial nerve function , and preservation of hearing. 
 
Conservative management is recommended for patients with small 
tumours who have a good possibility of not needing any treatment in their 
predicted natural life span. The obvious advantage of “wait and scan” is that 
it avoids a potentially morbid intervention. 
MICROSURGICAL MANAGEMENT 
 
The priorities in acoustic neuromas surgery  are the preservation of 
life, the maintainance of facial nerve function and the preservation of 
socially useful hearing in the tumour ear. Surgical procedures take place in 
two broad stages (1)Craniotomy and exposure of the tumour 
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(2)Microdissection of the tumour away from brain, cranial nerves and 
adjacent vascular elements. The most commonly used procedures are the 
retrosigmoid , translabyrinthine and middle fossa approach, others are 
transotic and extended middle fossa technique. 
 
STEREOTACTIC IRRADIATION: 
 
A precise , conformal dose of radiation with isodose lines tailored to 
the center margins of the tumour is given. A single large dose of irradiation 
is given in a single session to induce necrosis in the tissue , approximately 
25 Gy to the center and 12-14 Gy to the margins25. 
 
MENINGIOMAS 
 
Meningiomas arise from the meningothelial arachnoid cell and 
account for 13% - 18% of all the primary intracranial tumours. In the 
cerebellopontine angle it is the second most common and is a difficult 
differential diagnosis. 
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They are broad based  against a dural surface such as the posterior 
petrous wall and are usually eccentric to the porous, unlike acoustic 
schwannomas. Meningiomas frequently (56%) herniated into the middle 
fossa and are moderate to large tumours. 
 
Meningiomas are either isodense (31%) or hyperdense (69%) on non- 
contrast Computed Tomography and hypointense or isointense on T1- 
weighted images but are variable in intensity on T2-weighted images on 
Gadolinium Magnetic Resonance Imaging dural thickening surrounding a 
meningioma (“ dural tail, a meningeal sign or flair sign “) is seen in 52-72% 
of cases. Dural thickening bordering a meningioma extending into the 
Internal Auditory Canal may simulate the stem of an acoustic neuroma. The 
treatment of a meningioma is surgical. Local recurrences are not uncommon. 
 
EPIDERMOID AND OTHER CYSTS 
 
Also called primary cholesteatoma, or pearly tumours, congenital 
intradural epidermoid cysts are the third most common  tumour in the 
cerebellopontine angle. They present in middle adulthood, though congenital 
they tend to expand where physical resistance is low and so have variable 
shapes. On Computed Tomography they are nonenhancing and approximate 
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CSF in density.On Magnetic Resonance Imaging epidermoid cysts tend to be 
relatively homogenous, and are usually isointense or slightly hyperintense to 
CSF on T1- weighted images and are hyperintense to CSF on T2 weighted 
images.  
ARACHNOID CYST 
 
They are usually large masses, possess smoother surfaces than 
epidermoids and on Computed Tomograms, intrathecal contrast may be used 
to differentiate their surface characteristics. They are of the same density and 
intensity of CSF and are difficult to differentiate. Their symptoms may be 
controlled by diuretics. 
 
Cysticercosis is another diagnostic consideration in endemic areas. 
Lipomas and Dermoid cysts of the Internal Auditory canal and 
Cerebellopontine Angle can also cause Retrocochlear hearing loss. 
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MATERIAL AND METHODS 
 
Patients with diagnosed cerebellopontine angle space occupying 
lesions who came to the Neurotology Department of Upgraded Institute of 
Otorhinolaryngology of Government General Hospital, Chennai between the 
years 2007 – 2009 were included in the study, which consists of 30 cases. 
 
Inclusion Criteria: 
 
1)   Patients radiologically proven to have retrocochlear space 
occupying    lesions. 
2)    Patients having otologic symptoms. 
3)    Age group above 15 years . 
4)    Patients willing for the study. 
 
Exclusion Criteria: 
 
1) Patients with no otologic symptoms. 
2)       Patients less than 15 years. 
3)      Patients with life threatening complications. 
4)      Patients not willing for the study. 
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A total of 30 patients with radiological proven retrocochlear space 
occupying lesions and with otologic symptoms were evaluated 
audiologically, with Puretone Audiogram, Speech Audiometry, Caloric tests, 
and Brainstem Evoked Response Audiometry using a standardized case 
record form and statistics evaluated and  compared against standard series 
for reference.  
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TEST METHODS 
 
PURETONE AUDIOMETRY 
 
Puretone audiometry was done using MAICO MA52 audiometer. 
(Fig ii) The method used was modified Hughson Westlake ascending and 
descending method. Starting at 70dB reduce 10dB till the patient stops 
hearing. Then increase 5 dB each time till the threshold ie, minimum 
intensity, at which the patient can hear is reached . 
 
Hearing Loss is Graded as Follows: 
 
0 - 25dB Normal 
25- 40dB Mild 
40- 55dB Moderate 
56- 70dB Severe 
71- 90dB Profound 
>91dB Total Hearing Loss 
 
SPEECH AUDIOMETRY 
The audiometer used was MAICO MA52. 
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PURETONE AUDIOMETER 
 
 
 
BERA MACHINE   
 
 
Speech Reception Threshold 
 
The test begins with 25dB above the puretone threshold. A test of 10 
“spondee” words are the stimuli 25dB above the puretone average, which is  
reduced by 10dB till no response is obtained. Then increased by 5dB till the 
patient identifies 50% of the words.Repeat the procedure. The minimum 
intensity level at which the patient is capable of repeating 50% of the speech 
stimuli is the speech reception threshold. 
 
Speech Descrimination Score 
 
Phonetically balanced words are presented 40dB above the Speech 
Reception Threshold. A list of 50 words are given to the test ear and the 
percentage of correct responses is calculated. A score less than 30% 
indicates a retrocochlear pathology.  
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SPECIAL TESTS 
 
1) Tone Decay Test  
 
Olsen and Noffsinger method was used. 20dB suprathreshold stimulus 
is given to the test ear continuously for 1 min. If the patient hears for 1 
minute the test is negative and if it stops before 1 minute, it is positive and 
indicates retrocochlear pathology. This is done with 500Hz to 4kHz 
frequency. 
 
2) Suprathreshold Adaptation Test 
 
White noise of 90dB at 1kHz is used to mask the normal ear and 
110dB SPL is presented to the test ear continuously for one complete 
minute. If the patient hears for one complete minute the test is negative . If 
the patient hears for less than a minute the test is positive for  a retrocochlear 
pathology.   
 
3) Short Increment Sensitivity Test 
 
The test begins at 20dB above the puretone threshold and at a 
frequency of 1kHz. 1dB increment is presented  to the test ear twenty times. 
The percentage of the identified increments are  calculated. A score of more 
than 70% is indicates a cochlear pathology. 
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4) Alternate Binaural Loudness Balance Test 
 
From the threshold, 10dB is increased each time and the increment in 
intensity is compared with the opposite ear and plotted on a laddergram, and 
inference arrived based on the presence of recruitment in cochlear 
pathology. 
 
Brainstem Evoked Response Audiometry 
 
  
BERA was performed using USB Jr. (Universal Smart Box Jr.); 
Intelligent Hearing System. (Fig ii) Testing was conducted in a sound 
attenuating room with the patient in supine position.Scalp electrodes were 
placed at the vertex , high forehead and over the mastoids .A dual channel 
recording was thus obtained. The impedence was kept below 5000ohms. 
Rarefaction click stimuli at 90dB nHL at a rate of 11.1.per second were 
delivered through TDH-39 aural earphones.The band pass fillers were set at 
150-3000Hz (12dB per octave rolloff).The analysis time was set at 10ms and 
1024 average obtained for each recording. Atleast two trials performed on 
each side to get reproducible recordings.  The threshold for intreaural 
latency difference was set at 0.3 ms.  
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BERA WAVES IN RETROCOCHLEAR LESIONS 
 
WAVE III at 90 L(B) shows normal absolute latency  
 
 
 
Wave V at 90 L(B) shows increased absolute latency  (8.00ms) 
 
 
 
 
 
 
BERA WAVES SHOWING INCREASED ABSOLUTE LATENCY FOR 
WAVE V AND POOR MORPHOLOGY 
 
 
 
 
BERA REPORT SHOWING NO REPONSE AT 95 nHL 
 
 
 
Criteria Used for Diagnosis of Retrocochlear Pathology (Fig iii&iv) 
 
1) Prolongation of absolute latency of waves 1 , 3 , 5 
2) Prolongation of interaural latency 1-3 , 3-5 , or 1-5 
3) Poor wave form morphology 
4) Absent wave forms 
Magnetic Resonance Imaging 
 
Axial , Coronal , Sagittal sections with T1 weighted and T2 weighted 
images were done.Gadonilium- DTPA was given at a dose of 0.1 mmol/kg 
to look for enhancement of T1 weighted Magnetic Resonance images by its 
selective concentration in the tumours. The contrast material enters these 
tumours because of absence of blood-tissue barrier in the vascular bed of the 
tumour. These images were studied with special reference to the internal 
auditory canal and cerebellopontine angle to detect the abnormalities. 
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RESULTS AND ANALYSIS 
 
DEMOGRAPHIC PROFILE OF THE STUDY AGE (Fig. 1)   
 
The age of cases ranged from 18 to 72 years. 
The mean age was 43.4 years. 
The median age was 44.5 years. 
The mean age of acoustic schwannoma was 40.7 years. 
The mean age of meningioma was 58.8 years. 
 
SEX (Fig. 2) 
Females were found to be more affected. 
Males     - 46.7% 
Females  - 53.3% 
Male: Female ratio was 8 : 7 
TYPES OF LESIONS IN THE STUDY (FIG.3 ) 
 
The most commonly found lesions in the study were vestibular 
schwannomas consisting of 24 out of 30 cases.There were four cases of 
meningiomas, 1 arachnoid cyst and one astrocytoma. 
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AGE DISTRIBUTION (Fig.1 ) 
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SEX DISTRIBUTION (Fig.2 ) 
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TYPES OF LESIONS IN THE STUDY (FIG.3 ) 
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 Vestibular Schwannoma 80 % 
Meningioma 13 % 
Arachnoid Cyst 3.33 % 
Astrocytoma 3.33 % 
 
One case had bilateral vestibular schwannoma. 
 
SYMPTOMS (Fig.4 ) 
 
The first symptom was Hard of Hearing in 24 out of 30 cases. (80%). 
The first symptom was tinnitus in 6.7 % , headache in 13 %, and giddiness 
in 6.7% of cases. 
 
Both Hard of Hearing and Tinnitus 66.7% 
Only Hard of hearing 13% 
Only Tinnitus 6.7% 
Headache 40% 
Hypoaesthesia of face 13.3% 
Giddiness 23% 
Unsteadiness 13.3% 
 
Facial Nerve was found affected in 8 cases ; 26.7% of cases. 
One patient had facial tics on the side of the lesion. 
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SYMPTOMS: (FIG.4) 
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Two cases had symptoms of raised intracranial hypertension ; due to 
hydrocephalus. 
THE FREQUENCY OF SYMPTOMS 
 
The duration of symptoms ranged from 1 month to 3 years. 
The mean duration of symptoms was 1.45 years. 
The median duration of symptoms was 1 year and 4 months. 
 
PURETONE AUDIOGRAM (FIG.5) 
 
Cases with Mild Sensorineural Hearing loss were 7 (23.3%) 
Cases with Moderate Sensorineural Hearing Loss were 2 (6.67%) 
Cases with Severe Sensorineural Hearing Loss were 6 (20%) 
Cases with Profound Sensorineural Hearing Loss were 7 (23.3%) 
Cases with Total Sensorineural Hearing Loss were 7 (23.3%) 
1 case (3.33%) had a normal hearing. 
6 cases (20%) had a high frequency hearing loss. 
 
TONE DECAY TEST and SUPRATHRESHOLD ADAPTATION 
TEST  (FIG.6) 
 
13 cases out of 30 cases (43.3%) showed positive results ; indicating a 
retrocochlear pathology. 
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PURETONE AUDIOGRAM (FIG.5) 
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TONE DECAY TEST & SUPRATHRESHOLD  
ADAPTATION TEST (FIG.6) 
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These tests could not be done in 17 patients who had severe to 
profound hearing loss. 
 
 
SHORT INCREMENT SENSITIVITY INDEX  and ALTERNATE 
BINAURAL BALANCE TEST (FIG.7) 
 
13 cases had a SISI score of 30 – 40%. None of the cases showed 
recruitement phenomenon. 
In 17 cases with severe to profound hearing loss the tests could not  be done. 
 
BRAINSTEM EVOKED RESPONSE AUDIOMETRY (FIG.8) 
 
Cases with prolonged absolute latency of waves  was 14 (46.67%) 
Cases with prolonged interaural latency was 14 (46.67%) 
Cases with poor wave morphology  were 14  (46.67%) 
Due to profound hearing loss BERA showed no response in 14 
cases.(46.67%) 
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SHORT INCREMENT SENSITIVITY 
 
INDEX (FIG.7) 
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BRAINSTEM EVOKED RESPONSE AUDIOMETRY 
 
(FIG.8) 
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BERA showed a normal response in only two cases.(6.67%), thus 
showing a sensitivity of 93.3 % in detecting retrocochlear space occupying 
lesions 
 
Magnetic Resonance Imaging (FIG.9) 
Size of the tumours 
 
Small tumours <1cm Nil 
Moderate size 22 Cases 
Large size 8 Cases 
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TUMOUR SIZE: (FIG.9) 
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DISCUSSION 
Incidence of the Tumours 
 
Acoustic Neuromas consist of 60- 90% of all cerebellopontine angle 
tumours. 
 
In this study 80% of cerebellopontine angle tumours were acoustic neuromas. 
Meningiomas consist of 6.8% of cerebellopontine angle tumours (valavani’s 
et al ) or 6.3% (Gonzalez Revilla) 
 
In this study 13% of the tumours were meningiomas. 
 
Female predilection has been noted in some studies for both acoustic 
neuromas and meningiomas. In this study 53.3% are females. 
 
The average age of sporadic Acoustic Neuromas is 50 years, whereas 
in NF2 patient presents at a younger age with a mean age of 31 years. In this 
study the mean age is 43.4 years .One case in this study of bilateral vestibular 
schwannoma had an age of 18 years. 
 
Regarding meningiomas the peak incidence is in the 6th and 7th decade 
of life, which in this study was found to be 58.8 years. 
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Symptomatology of Retrocochlear 
Space Occupying Lesions 
 
Majority of studies verify that the initial or presenting symptom is 
hearing loss with or without tinnitus in about 80 % of patients, which in this 
study is also found to be 80 %. 
 
Tinnitus as the only presenting symptom is found in about 7 % of 
patients and hearing loss without tinnitus is identified in between 40% and 
80%. In this study the cases with only tinnitus as the presenting symptom 
was found to be 6.7% and cases with hearing loss alone as the presenting 
symptom was 13 %. 
 
In meningioma series tinnitus was identified in only 34% to 50% of 
patients at diagnosis. 
 
The average number of years from the onset of symptoms to diagnosis 
is about 4 according to Selesnick & collegues in 199226; which in this study 
was found as 1.5 years. 
 
The time from the onset of symptoms to the diagnosis is less than 1 
year in only about 20 % of patients, which was found as 26 % in this study. 
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In various studies , 3% -22% of patients have three frequency Puretone 
average threshold better than 20- 25dB and 16% - 45%of patients have 
Puretone average less than 70dB. In this study, 3.3% had Puretone average 
better than 20-25dB and 53.3 % had Puretone averages less than 70 dB. 46.6 
% were found to have a Puretone average above 70 dB.  
 
 The symptoms of hearing loss or tinnitus are independent of tumour 
size but there is a definite trend toward normal hearing in tumour less than 1 
cm. 
 
     Speech discrimination for the eighth nerve tumour patients is quite poor. 
Selesnick and coworkers26 found that patients with less than 1cm in diameter 
had an average puretone loss of 40dB and 50% of those patients had a SDS 
of greater than 81% and the series of less than 2cm tumour of Dornhoffer27 
found 37% with normal speech discrimination. In patients with medium and 
large tumours , the average speech reception threshold was 47 and 58dB 
respectively and only 25% of patients with medium a large tumours had an 
SDS better than 81%. 
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 In this study, speech audiometry and special tests could be done only 
in 43% of cases, the rest having severe-total hearing loss, and a result 
indicating a retrocochlear pathology could be obtained in all the 43% cases.  
The majority of series demonstrate about a 5% to 7% incidence of 
truly normal hearing , which in this study was 3.33% 
Brainstem Evoked Response Audiometry 
 
Selters and Brackmann, House and Brackmann and Clemis and 
McGee in 1970s demonstrated 92% - 98% sensitivity for absent or abnormal 
Auditory Brainstem Response  in Acoustic Neuroma patients. Auditory 
Brainstem Response shows a consistent asynchronous retrocochlear pattern 
in tumours more than 2 cm but in intracanalicular tumours, a much greater 
percentage will show a normal pattern. 
 
Grabel et al in 199128 stated that 30% of intracanalicular tumours 
showed a normal Auditory Brainstem Response. 
 
Gordon in 199529 stated that 31% of intracanalicular tumours and 
15.5% of tumours less than 1.5cm showed a normal Auditory Brainstem 
Response. 
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Brainstem Evoked Response Audiometry in other retrocochlear 
lesions: 
 
Laird and coworkers30 and Granick and collegues31 had a series of 
meningiomas of the posterior fossa of all of which showed a positive 
Auditory Brainstem Response. 
 
House and Brackmann32 demonstrated that only 75% of 
cerebellopontine angle lesions that were not acoustic neuromas had an 
abnormal Acoustic Brainstem Response. 
 
Brainstem evoked response audiometry showed results corresponding 
to retrocochlear pathology in 46.7% of cases and a normal result in 6.67% of 
cases. Due to hearing loss more than 70 dB, Brainstem evoked response 
audiometry showed no response in the remaining 46.7%, hence being 
sensitive upto only 93% ; two cases which showed  normal Brainstem 
evoked response audiometry waves were posterior cranial fossa 
meningiomas. 
 
Marangos and coworkers33 found 23.5% of meningiomas had a 
normal Auditory Brainstem response. 
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MAGNETIC RESONANCE IMAGING  
 
 The sensitivity of contrast enhanced T1 – weighted MR imaging can 
approach 100% in detecting schwannomas31 . 
 In the study, all the cases were diagnosed by contrast enhanced MRI. 
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 CONCLUSION 
 
A high index of suspicion needs to be maintained when symptoms of 
unilateral hearing loss and tinnitus co-exist in a patient. The patient then has 
to undergo a battery of audiological tests to rule a retrocochlear lesion. 
 
The first line audiological investigation is the PureTone Audiometry, 
but which cannot differentiate a cochlear from a retrocochlear lesion. 
 
The speech audiometry and special tests (SISI, TDT, ABLB etc.) are 
useful in differentiating cochlear from retrocochlear lesions. They have 
limitations when it comes to patients with hearing loss more than 60 dB. 
 
The sensitivity of Brainstem Evoked Response Audiometry in 
detecting retrocochlear lesion is found to be 93% in this study, with an 
advantage of detecting the site of the lesion. This test also has limitations 
when it comes to patients with hearing loss more than 60dB. 
 
No audiological test is 100 % sensitive in detecting retrocochlear 
lesions but when applied together the chance of early detection is increased. 
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The sensitivity of Gadolinium Enhanced Magnetic Resonance 
Imaging reaches almost 100%, thus leaving it as the gold standard 
investigation for diagnosis of the condition. 
 
Taking into account of the cost factor of Gadolinium enhanced 
Magnetic Resonance Imaging, it cannot be used as a screening test, whereas 
Brainstem Evoked Response Audiometry can be used to screen for 
retrocochlear space occupying lesions when there is a high index of 
suspicion.  
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PROFORMA FOR OTONEUROLOGICAL DIAGNOSIS OF 
RETROCOCHLEAR LESIONS 
 
S.No: 
Name: 
Address: 
Hospital No: 
Sex: 
Date of study: 
Age: 
Total Duration of Symptoms: 
First Symptom: 
Symptoms:                                                                  Duration: 
Vestibulocochlear 
Tinnitus 
            Ipsilateral/Contralateral 
            Continuos/Episodic 
Hearing Loss 
            Unilateral/Bilateral 
            Sudden/Gradual 
Vertigo 
            Episodic/Continuous 
            Vomiting 
            Frequency of attacks 
            Duration 
Facial Nerve: 
           Weakness 
           Taste 
Trigeminal Nerve: 
           Sensory impairement 
           Motor symptoms 
Cerebellar: 
          Unsteadiness 
          Incordination 
          Dysarthria 
Others 
          Headache 
          Headache with vomiting 
          Drowsiness 
          Nasal regurgitation 
64 
          Change of voice 
Neurological Examination: 
7th nerve 
House and Brackmann Grading 
Taste 
8th Nerve 
Rinne 
Weber 
5th Nerve 
Sensory: V1 
               V2 
               V3 
Motor: 
Corneal Reflex 
9th and 10th 
Cerebellar: 
Nystagmus 
Truncal Ataxia 
Appendicular Ataxia 
Pyramidal Signs 
Others: 
Audiological Tests: 
Pure tone audiometry: High Frequency Loss 
                                    Low Frequency Loss 
BERA: 
Normal 
Retrocochlear 
No Response 
MRI 
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MASTER CHART 
S. 
No. Hosp.No Name Age Sx Dur S1 HL TI GD FS GT OS PTA 
SDS TDT, 
STAT SISI BERA MRI 
1 658/08 Neelavathy 58 F 7m HL Y Y Y N N FP SNHLSev <30% +ve 30% NR AN 
2 836/08 Sumathi 26 M 1m HL Y Y N N N HF SNHLMild <30% +ve 30% RC AN 
3 1029/08 Ravichandran 50 M 6m HL Y Y Y N N HA SNHLProf - _ _ RC AN 
4 2660/08 Johnson 20 M 1.5Yr HL Y Y N N N HA SNHLSev <30% + 30% NR AN 
5 3661/08 Shanthi 40 F 2Yr HL Y Y N Y N _ SNHLMod <30% +ve 30% RC AN 
6 5695/08 Rajendran 50 M 2Yr TI Y Y N N N _ SNHLMild <30% +ve 30% RC AN 
7 7605/08 Vijaya 30 F 1.5Yr HL Y Y N N N _ SNHLSev - _ _ RC AN 
8 34214/08 Lakshmi 50 F 3Yrs GD Y Y Y N N HA HFSNmild <30% +ve 30% RC AC 
9 36123/08 Murugyan 35 M 1Yr TI Y Y Y N N _ SNHLProf - _ _ NR AN 
10 40544/08 Amuda 46 F 3Yrs HA N N Y Y N HA HFSNmild <30% +ve     20%, RC AN 
11 46347/08 Umapathy 31 M 2Yrs HL Y Y Y N N _ SNHLProf - _ _ RC AN 
12 47222/08 Thilaka 32 F 2Yrs HL Y Y Y N N US HFHLmild <30% +ve 30% RC AN 
13 48564/08 Pachiappan 67 M 6m HL Y Y Y N N _ Nl HG <30% +ve 30% RC MG 
14 53218/08 Vijaya 46 F 1.5Yrs HL Y Y N N N HA SNHLsev - _ _ RC AN 
15 62814/08 Rajendran 18 M 1Yr HL Y Y N N N _ SNHLProf - _ _ NR AN-
BL 
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 S.No. Hosp.No Name Age Sex Dur S1 HL TI GD FS GT OS PTA SDS TDT, 
STAT 
SISI BERA MRI 
16 83665/08 Govindaraj 67 M 6m HA N N N N N _ HFSNmild <30% +ve 30% NL MG 
17 86933/08 Rajeswari 50 F 1.5Yr HA Y N N Y N _ SNHLTot - _ _ RC AN 
18 618/09 Vasuki 39 F 3Yr HL Y Y Y N N _ SNHLTot - _ _ NR AS 
19 871/09 Venkatesan 44 M 1Yr HL Y Y Y N N _ SNHLSev <30% +ve 30% NR AN 
20 969/09 Arunkumar 32 M 2Yr HL Y Y N N N _ SNHLTot - _ _ NR AN 
21 1597/09 Muraleedaran 45 M 6m HL Y Y Y Y N US SNHLSev <30% +ve 30% RC AN 
22 1627/09 Geetha 29 F 2Yr HL Y Y N N Y _ SNHLProf - _ _ NR AN 
23 2642/09 Violet 58 F 2.5Yr HL Y Y N N N HA SNHLMod <30% +ve 30% NL MG 
24 3678/09 Kousalya 19 F 2Yr HL Y Y N N N _ SNHLTotal - _ _ NR AN 
25 4435/09 Balasubramaniam 55 M 1Yr HL Y Y N N N _ SNHLTot - _ _ NR AN 
26 4675/09 Dhanabakiyam 72 F 6m TI Y Y N N N _ SNHLTotal - _ _ NR AN 
27 7044/09 Thamimansari 40 M 1Yr HL Y Y N N N HA SNHLProf - _ _ NR AN 
28 8614/09 Kousalyam 39 M 1Yr HL Y Y Y N N N SNHLProf - _ _ NR AN 
29 46161/09 Karimullah 50 M 3Yr HA Y N N N N HA SNHLTot - _ _ NR AN 
30 86933/09 Rajeswari 55 F 1.5Yr HL Y Y N N N _ SNHLTot - _ _ NR AN 
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LEGEND FOR MASTER CHART 
 
S1:First Symptom 
HL:Hearing Loss 
TI:Tinnitus 
GD:Giddiness 
FS:Facial Sensory Abnormality 
GT:Gait Abnormality 
OS:Other Symptoms 
HA:Headache 
FP:Facial Palsy 
HF:Hemifacial Spasm 
US:Unsteadiness 
PTA:Puretone Audiogram 
SNHL:Sensorineural Hearing Loss 
Mild  
Mod- Moderate 
Sev-Severe 
Prof-Profound 
SDS-Speech Descrimination Score  
TDT:Tone decay Test 
STAT:Suprathreshold Adaptation Test 
SISI:Short Increment Sensitivity Index 
BERA:Brainstem Evoked Response Audiometry 
NR:No Response 
RC:Retrocochlear 
NL:Normal 
AN:Acoustic Neuroma 
MG:Meningioma 
AC:Arachnoid Cyst 
AS:Astrocytoma 
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PATIENT CONSENT FORM 
Study Detail:  Comprehensive Study of Audiological Evaluation of Retrocochlear Space 
Occupying Lesions   
Study Centre : Upgraded Institute  of Otorhinolaryngology, 
   Madras Medical College & Government  General Hospital, Chennai -3 
  Institute of Child health, Egmore, Chennai 600 008. 
 
Patient Name    : 
Patient Age    : 
Identification Number  : 
        Patient may tic () these 
boxes 
 I confirm that I have understood the purpose of procedure for the above Study.  I 
have  the opportunity  to ask the question and all my questions and doubts  have been 
answered to my satisfaction. 
 
 I understand that my participation  in  the study  is voluntary and that I am free to 
withdraw at anytime without giving any reason, without my legal rights being effected. 
 
 I understand that Investigator, Regulatory authorities and the Ethics committee 
will not need my permission to look at my health records both in respect to the current 
study and any further research that may be conducted in relation to it, even if withdraw 
fro the study. I understand that my  identity  will not be revealed in any information  
released to third parties or published, unless  as required under the law. I agree not to 
restrict the use of any data or results that arise from the study.  
 
 I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully co operative with the study team and to immediately 
inform the study staff if I suffer from any deterioration in my health or well being or any 
unexpected or unusual symptoms, 
 
 I hereby con sent to participate in this study. 
 
 I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, radiological tests. 
 
 
Signature/Thumb Impression:  Place   Date 
Patient Name and Address: 
 
Signature of the Investigator:   Place    Date 
Study Investigator’s Name: 
 
 
 
 
 
 
 
 
 
                                    
